Dipartimento di Medicina Interna, University of Genoa, Genoa, Italy.
Liver Int. 2011 Feb;31(2):192-6. doi: 10.1111/j.1478-3231.2010.02409.x. Epub 2010 Dec 10.
Chronic hepatitis B virus (HBV) infection is one of the most frequent aetiological factors associated with the development of hepatocellular carcinoma (HCC).
This study evaluated the temporal trend in the aetiological role played by HBV infection alone in patients diagnosed with HCC during the last 20 years in Italy.
Among the 2042 HCC patients included in the Italian Liver Cancer (ITA.LI.CA.) database, 346 had chronic HBV infection alone. We assessed the proportion of HCC patients with HBV infection in four quinquennia (1987-1991, 1992-1996, 1997-2001, 2002-2006) and evaluated their main clinical, virological and oncological characteristics across these periods.
Although the absolute number increased, the proportion of HBV-related HCC relatively decreased over time from 26.7% (47/176 patients) in 1987-1991 to 14.7% (127/862 patients) in 2002-2006 (P=0.0005). Patients' demographical, clinical and virological characteristics were similar across the four quinquennia. A greater proportion of patients was diagnosed with non-advanced HCC in more recent years (from 26% in 1987-1991 to 48% in 2002-2006, P=0.025), likely owing to a growing use of semiannual surveillance (from 63% in 1987-1991 to 80% in 2002-2006).
We observed a significant, relative decrease in the role played by chronic HBV infection alone in the determinism of HCC during the last 20 years. In recent years, more patients are diagnosed with non-advanced HCC probably owing to improvements in HCC detection.
慢性乙型肝炎病毒(HBV)感染是导致肝细胞癌(HCC)发生的最常见病因之一。
本研究评估了过去 20 年中意大利单独由 HBV 感染引起 HCC 的病因学作用的时间趋势。
在意大利肝癌(ITA.LI.CA.)数据库中纳入的 2042 例 HCC 患者中,有 346 例为慢性 HBV 感染。我们评估了四个 5 年期间(1987-1991 年、1992-1996 年、1997-2001 年、2002-2006 年)中 HBV 感染 HCC 患者的比例,并评估了这些时期内他们的主要临床、病毒学和肿瘤学特征。
尽管绝对数量有所增加,但随着时间的推移,HBV 相关 HCC 的比例相对下降,从 1987-1991 年的 26.7%(47/176 例)降至 2002-2006 年的 14.7%(127/862 例)(P=0.0005)。四个 5 年期间患者的人口统计学、临床和病毒学特征相似。近年来,更多的患者被诊断为非晚期 HCC(从 1987-1991 年的 26%增加至 2002-2006 年的 48%,P=0.025),这可能归因于半年一次的监测使用率的增加(从 1987-1991 年的 63%增加至 2002-2006 年的 80%)。
在过去 20 年中,我们观察到单独由慢性 HBV 感染引起 HCC 的作用显著下降,相对降低。近年来,更多的患者被诊断为非晚期 HCC,可能是由于 HCC 检测水平的提高。